Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 315
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2180circCDK13circRNAsHumanSuppressed expression in liver cancer DiagnosticNormal cell line vs cancer cell line p < 0.05Tissue29658568
2199MTHFRRNAsHumanMTHFR polymorphism was associated with HCC occurrence PrognosticNormal vs HCC; predict recurrence in patients p < 0.05Tissue29185200
2246HLA-CRNAsHumanUpregulated in HCC and CHC v/s normal (with 67 fold change) DiagnosticHCC and CHC v/s normal p < 0.01Tissue11401510
2247B2MRNAsHumanUpregulated in HCC and CHC v/s normal (with 67 fold change) DiagnosticHCC and CHC v/s normal p < 0.01Tissue11401510
2248BR1RNAsHumanUpregulated in HCC and CHC v/s normal (with 19 fold change) DiagnosticHCC v/s CHC and normal p < 0.01Tissue11401510
2249GPC3RNAsHumanUpregulated in HCC than CHC and normal (with nearly 15 fold change) DiagnosticHCC v/s CHC and normal p < 0.01Tissue11401510
2250UBDRNAsHumanUpregulated in HCC than CHC and normal (with nearly 12 fold change) DiagnosticHCC v/s CHC and normal p < 0.01Tissue11401510
2251CXCL10RNAsHumanUpregulated in HCC than CHC and normal (with nearly 13 fold change) DiagnosticHCC v/s CHC and normal p < 0.01Tissue11401510
2252CYP3A4RNAsHumanDownregulated in HCC than CHC and normal (with nearly 42 and 50 fold change) DiagnosticHCC v/s CHC and normal p < 0.01Tissue11401510
2253CYP4A11RNAsHumanDownregulated in HCC than CHC and normal (with nearly 17 and 30 fold change) DiagnosticHCC v/s CHC and normal p < 0.01Tissue11401510
2254SLC22A1RNAsHumanDownregulated in HCC than CHC and normal (with nearly 8 and 17 fold change) DiagnosticHCC v/s CHC and normal p < 0.01Tissue11401510
2260CDK4RNAsHumanUpregulated Diagnostic and prognosticHCC with Cirrhosis v/s HCC without Cirrhosis p < 0.05Tissue18959789
2261BaxRNAsHumanUpregulated Diagnostic and prognosticHCC with Cirrhosis v/s HCC without Cirrhosis p < 0.05Tissue18959789
2262NOTCH4RNAsHumanUpregulated Diagnostic and prognosticHCC with Cirrhosis v/s HCC without Cirrhosis p < 0.05Tissue18959789
2263ISGF3GRNAsHumanDownregulated Diagnostic and prognosticHCC with Cirrhosis v/s HCC without Cirrhosis p < 0.05Tissue18959789
2264TNFRNAsHumanDownregulated Diagnostic and prognosticHCC with Cirrhosis v/s HCC without Cirrhosis p < 0.05Tissue18959789
2265VISARNAsHumanDownregulated Diagnostic and prognosticHCC with Cirrhosis v/s HCC without Cirrhosis p < 0.05Tissue18959789
2266AURKB-Sv2 variantRNAsHumanUpregulated in metastatic HCC than primary HCC and Absent in normal PrognosticMetastatic HCC v/s Primary HCC; correlated with a poor outcome and short disease-free period p < 0.01Cell line and Tissue19134008
2267SPP1RNAs and ProteinHumanUpregulated in PT than PN (with 3 fold change) DiagnosticMetastatic HCC v/s Primary HCC p < 0.01Tissue12640447
2268LIMK1, CENPE, FZD2, ENO2, ITGA9, COPA, KIAA0660, GTF2H1, VPS41, RGS20, MATK, STOML1, BASP1, EPB42, ALDH3B2, MEL, CAT56, RAB3A, PSCD3, PLD2, ADCYAP1R1, ALDH3B1, RHD, CSF3R, KIAA0063, KIAA0296, LRP6, ENO3, CTRB1, YES1, IncytePD:1404153, GYS1, MDFI, GABRE, IncytePD:2685601, CD3Z, DTYMK, SPTBN2, IncytePRNAsHumanUpregulated in PT than PN (with 3 fold change) DiagnosticMetastatic HCC v/s Primary HCC p < 0.01Tissue12640447
2292RPS5RNAsHumanUpregulated in HBV associated HCC (v/s normal samples with fold change 6.35) and (v/s HCV associated HCC with ratio of 2.38) DiagnosticHBV associated HCC v/s normal and HCV associated HCC p < 0.05Tissue18932288
2293KRT8RNAsHumanUpregulated in HBV associated HCC ( v/s normal with fold change 5.68) and (v/s HCV associated HCC with ratio 3.19) DiagnosticHBV associated HCC v/s normal and HCV associated HCC p < 0.05Tissue18932288
2294CFLARRNAsHumanUpregulated in HBV associated HCC (v/s normal samples with fold change 2.86) and (v/s HCV associated HCC with ratio of 2.09) DiagnosticHBV associated HCC v/s normal and HCV associated HCC p < 0.05Tissue18932288
2295ATP5F1RNAsHumanUpregulated in HBV associated HCC (v/s normal samples with fold change 4.19) and (v/s HCV associated HCC with ratio of 3.52) DiagnosticHBV associated HCC v/s normal and HCV associated HCC p < 0.05Tissue18932288
2296IGFBP2RNAsHumanUpregulated in HBV associated HCC (v/s normal samples with fold change 3.37) and (v/s HCV associated HCC with ratio of 2.49) DiagnosticHBV associated HCC v/s normal and HCV associated HCC p < 0.05Tissue18932288
2297MAP3K5RNAsHumanUpregulated in HBV associated HCC (v/s normal samples with fold change 3.76) and (v/s HCV associated HCC with ratio of 2.33) DiagnosticHBV associated HCC v/s normal and HCV associated HCC p < 0.05Tissue18932288
2298MMP9RNAsHumanUpregulated in HBV associated HCC (v/s normal samples with fold change 7.43) and (v/s HCV associated HCC with ratio of 3.74) DiagnosticHBV associated HCC v/s normal and HCV associated HCC p < 0.05Tissue18932288
2299VIMRNAsHumanUpregulated in HCV associated HCC (v/s normal samples with fold change 8.61) and (ratio of HBV-HCC v/s HCV-HCC 0.28) DiagnosticHCV associated HCC v/s normal and HBV associated HCC p < 0.05Tissue18932288
2300ACTBRNAsHumanUpregulated in HCV associated HCC (v/s normal samples with fold change 4.13) and (ratio of HBV-HCC v/s HCV-HCC 0.37) DiagnosticHCV associated HCC v/s normal and HBV associated HCC p < 0.05Tissue18932288
2301GAPDRNAsHumanUpregulated in HCV associated HCC (v/s normal samples with fold change 5.27) and (ratio of HBV-HCC v/s HCV-HCC 0.29) DiagnosticHCV associated HCC v/s normal and HBV associated HCC p < 0.05Tissue18932288
2302CD58RNAsHumanUpregulated in HCV associated HCC (v/s normal samples with fold change 4.68) and (ratio of HBV-HCC v/s HCV-HCC 0.31) DiagnosticHCV associated HCC v/s normal and HBV associated HCC p < 0.05Tissue18932288
2303CD24RNAsHumanUpregulated in the high-risk group PrognosticEarly recurrence of HCC v/s Late recurrence of HCC p < 0.001Tissue18381945
2304CLDN10RNAsHumanUpregulated in Cirrhosis v/s control and early and advanced HCC DiagnosticCirrhosis v/s Low/High grade dysplastic nodules, normal and early/Late HCC p < 0.05Tissue17393520
2305GREM2RNAsHumanUpregulated in dysplasia v/s control and early/advanced HCC Diagnosticdysplasia v/s early/late HCC and normal p < 0.05Tissue17393520
2306EPORNAsHumanUpregulated in dysplasia v/s control and early/advanced HCC Diagnosticdysplasia v/s early/late HCC and normal p < 0.05Tissue17393520
2307NRG1RNAsHumanUpregulated in dysplasia v/s control and early/advanced HCC Diagnosticdysplasia v/s early/late HCC and normal p < 0.05Tissue17393520
2308ASPMRNAsHumanUpregulated in early/advanced HCC v/s control and dysplasia Diagnosticdysplasia v/s early/late HCC and normal p < 0.05Tissue17393520
2309PRIM1RNAsHumanUpregulated in early/advanced HCC v/s control and dysplasia Diagnosticdysplasia v/s early/late HCC and normal p < 0.05Tissue17393520
2310HMMRRNAsHumanUpregulated in early/advanced HCC v/s control and dysplasia Diagnosticdysplasia v/s early/late HCC and normal p < 0.05Tissue17393520
2311IRAK1RNAsHumanUpregulated in early/advanced HCC v/s control and dysplasia Diagnosticdysplasia v/s early/late HCC and normal p < 0.05Tissue17393520
2312C/EBPRNAsHumanDownregulated in cancer DiagnosticHCC v/s non-tumor HCC NATissue11306505
2313HNF-1RNAsHumanUpregulated in cancer DiagnosticHCC v/s non-tumor HCC NATissue11306505
2314HNF-3betaRNAsHumanUpregulated in cancer DiagnosticHCC v/s non-tumor HCC NATissue11306505
2315HNF-4alphaRNAsHumanUpregulated in cancer DiagnosticHCC v/s non-tumor HCC NATissue11306505
2316HNF-4gammaRNAsHumanUpregulated in cancer DiagnosticHCC v/s non-tumor HCC NATissue11306505
2317NDRG2Protein and RNAsHumanDownregulated in HCC than non-tumor Diagnostic and PrognosticHCC v/s cirrhosis/healthy/non-tumor HCC; associated with recurrence and tumor grade p < 0.05Tissue18519680
2318CSTBProtein and RNAsHumanUpegulated in HCC than non-tumor DiagnosticHCC v/s cirrhosis/healthy/non-tumor HCC p < 0.05Serum18281540
2321TGF betaRNAsHumanUpegulated in HCC than non-tumor Prognosticearly occurrence v/s late recurrence NATissue20380719
2322MycRNAsHumanUpegulated in HCC than non-tumor Prognosticearly occurrence v/s late recurrence NATissue20380719
2323LOC388796, A_32_P406142, SAFB, MKL1, TNKS1BP1, PMM2, PPP2R5C, SAFB2, GATA4, RASD1, KIAA1967,RNAsHumanover expressed in subjects with fastest recurrence Prognosticearly occurrence v/s late recurrence p < 0.0001Tissue20380719

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top